Stage iva prostate cancer ajcc v8 Trials in San Francisco, United States
Conditions / Stage iva prostate cancer ajcc v8 / San Francisco, United States
Stage iva prostate cancer ajcc v8 has been the subject of sustained clinical investigation across multiple research sites.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04716725 | 68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04134260 | Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial | RECRUITING | PHASE3 |
| NCT05113537 | Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer | RECRUITING | PHASE1/PHASE2 |
| NCT05946213 | Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer | RECRUITING | PHASE3 |
| NCT04455750 | A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04471974 | ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04513717 | Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04976257 | Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion | COMPLETED | EARLY_PHASE1 |
| NCT03678025 | Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer | RECRUITING | PHASE3 |
| NCT04927663 | 11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression | TERMINATED | PHASE1 |